AI In Healthcare

Research Article • Article ID: IJREK-2026-00135

Authors & Institutional Affiliations
kauravi bhamareCorresponding Author
Dattakala Group Of Institutions Faculty Of Engineering Swami - Chincholi tal. Daund dist. Pune
kauravibhamare@gmail.com
Guide / Supervisor:Ms.Gawand R.R.

Abstract

Artificial Intelligence (AI) is transforming healthcare by supporting clinical decision-making, medical image analysis, disease prediction, personalized treatment, drug discovery, and remote patient monitoring. Machine learning, deep learning, natural language processing, and computer vision enable healthcare systems to extract useful information from medical images, electronic health records, laboratory reports, and physiological signals. These capabilities can assist healthcare professionals in identifying potential abnormalities, estimating clinical risks, and improving the organization of patient care. However, the practical adoption of AI introduces important challenges, including data privacy, algorithmic bias, limited interpretability, cybersecurity threats, regulatory compliance, and the need for clinical validation. An AI system that performs well on a development dataset may not achieve the same performance in a different hospital or patient population. Therefore, accuracy alone is insufficient to establish clinical usefulness. This paper reviews the major AI technologies used in healthcare, presents a generalized architecture for AI-enabled clinical systems, examines representative applications, and discusses their benefits, limitations, and ethical implications. It also explores future directions involving explainable AI, federated learning, multimodal models, and human–AI collaboration. The review emphasizes that AI should complement clinical expertise rather than replace professional judgment. Responsible implementation requires reliable data, independent validation, transparent evaluation, appropriate governance, and continuous monitoring after deployment. Index Terms—Artificial Intelligence, Healthcare, Machine Learning, Deep Learning, Medical Imaging, Clinical Decision Support, Explainable AI, Healthcare Data Privacy.

Keywords

Cyber securityMachine LearningArtificial Intelligence

I. INTRODUCTION

Healthcare organizations generate large amounts of information through electronic health records (EHRs), medical imaging equipment, laboratory systems, wearable devices, and clinical documentation. Interpreting these heterogeneous data sources is difficult because they vary in format, quality, volume, and clinical context. Artificial Intelligence (AI) provides computational methods that can identify patterns in large datasets and produce predictions or recommendations that support healthcare professionals. AI is an umbrella term that includes machine learning (ML), deep learning (DL), natural language processing (NLP), computer vision, and other computational techniques. Machine learning algorithms learn relationships from data, while deep learning uses multilayer neural networks to represent complex patterns. Computer vision supports the analysis of medical images, whereas NLP extracts information from clinical notes and medical documents. The use of AI in healthcare has expanded from experimental research to applications such as radiology assistance, pathology analysis, patient risk assessment, clinical workflow support, and medical research. Esteva et al. demonstrated the potential of deep neural networks for classifying skin cancer images, illustrating how image-based AI could contribute to specific diagnostic tasks [1]. Rajpurkar et al. reviewed the use of deep learning across medical imaging and highlighted both its opportunities and its limitations [3]. Despite these advances, healthcare is a high-stakes environment. Incorrect predictions can delay treatment, generate unnecessary investigations, or create false reassurance. Models may also perform unequally across patient groups or fail when the data encountered in practice differ from the training data. AI outputs therefore require clinical interpretation, validation, and appropriate oversight. This paper presents a structured review of AI technologies, healthcare applications, system architecture, implementation considerations, ethical concerns, and emerging research directions.

A. Objectives The main objectives of this review are:

  • To explain the principal AI technologies used in healthcare.
  • To describe a generalized architecture for AI-enabled healthcare systems.
  • To review major applications in diagnosis, treatment, monitoring, and medical research.
  • To summarize potential benefits and practical limitations.
  • To examine ethical, privacy, security, and regulatory concerns.
  • To identify future directions for responsible AI adoption. B. Scope of the Review This paper focuses on the general use of AI in clinical and healthcare settings. It discusses established research approaches and representative applications rather than evaluating a single deployed product. Performance depends on the clinical task, data quality, validation method, patient population, and intended use. Consequently, the applications discussed here should not be interpreted as proof that every AI system is clinically effective.

II. BACKGROUND AND AI TECHNOLOGIES

AI-enabled healthcare systems combine computational models with medical knowledge, clinical data, and healthcare workflows. Different techniques are suitable for different kinds of information and problems. A. Machine Learning Machine learning algorithms identify statistical relationships in examples and use them to make predictions on new observations. Supervised learning uses labelled examples for tasks such as disease classification and readmission prediction. Unsupervised learning identifies patterns or groups without predefined labels. Reinforcement learning studies sequential decision-making through feedback, although its use in clinical care requires particularly careful safety evaluation. Traditional ML methods, including decision trees, random forests, support vector machines, and gradient-boosting models, may be useful when working with structured information such as age, laboratory measurements, medical history, and vital signs. B. Deep Learning Deep learning uses neural networks with multiple processing layers. Convolutional neural networks (CNNs) are widely associated with image analysis, while recurrent networks and transformer-based models can process sequential or textual information. Deep learning can learn complex representations from data but often requires substantial training data, computing resources, and careful validation. C. Natural Language Processing NLP techniques process human language. In healthcare, they can assist with extracting medical concepts from clinical notes, summarizing documents, searching medical literature, and organizing unstructured records. Language models can produce fluent text, but their outputs may contain incorrect or unsupported statements. Clinical verification is therefore essential. D. Computer Vision Computer vision analyzes visual information such as X- rays, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound images, and digital pathology slides. Depending on the task, a model may classify an image, identify a region of interest, segment an anatomical structure, or estimate a measurement. E. Generative AI Generative AI creates new content, including text, images, or other data representations. In healthcare, potential uses include clinical documentation assistance, patient education drafts, research support, and synthetic-data experimentation. Such systems require safeguards against fabricated information, privacy leakage, and inappropriate automation.

III. LITERATURE REVIEW

Research in AI-enabled healthcare has developed across medical imaging, clinical prediction, language processing, and clinical decision support. Esteva et al. investigated deep neural networks for classification of skin cancer images and demonstrated the potential of image-based learning for selected diagnostic tasks [1]. Their work helped establish deep learning as an important research direction in medical image analysis. Topol discussed the potential of high-performance AI to support healthcare professionals and emphasized the importance of combining technological capability with human expertise [2]. This perspective is important because clinical decisions involve patient preferences, uncertainty, communication, and contextual knowledge that may not be fully represented in a dataset. Rajpurkar et al. examined deep learning in medical imaging, including the opportunities for automated image interpretation and the challenges of translating research systems into clinical practice [3]. Liu et al. reviewed the performance of deep learning and healthcare professionals in medical imaging tasks, showing why evaluation design and the comparison being made must be considered carefully [4]. Miotto et al. reviewed deep learning methods for healthcare and discussed how these approaches can learn from heterogeneous medical data [5]. Jiang et al. described a broad range of AI applications in healthcare, including diagnosis, treatment, and health management [6]. Obermeyer et al. demonstrated how a widely used healthcare risk-prediction algorithm could produce racial bias because its target was based on healthcare costs rather than the actual level of illness [7]. This finding illustrates that bias can originate from the way a problem is defined, even when a model is trained using a large dataset. The World Health Organization (WHO) has also highlighted the need for ethical governance of AI in health, including transparency, accountability, privacy, and the protection of human rights [8]. These principles are necessary when translating technical research into systems that affect patients. Overall, the literature demonstrates substantial potential for AI in healthcare while identifying persistent challenges involving generalizability, data quality, fairness, interpretability, and clinical integration.

IV. GENERALIZED ARCHITECTURE OF AI IN HEALTHCARE

An AI-enabled healthcare system typically includes data acquisition, preprocessing, model development, inference, clinical integration, and monitoring. The architecture varies according to the clinical task, the available infrastructure, and the intended use of the system. A. Architecture Overview

Fig. 1 presents a generalized architecture for an AI-assisted healthcare system. The diagram represents a conceptual workflow rather than a specific implemented product. B. Data Acquisition The data acquisition layer collects information from authorized sources such as EHRs, laboratory systems, medical imaging equipment, wearable devices, and patient monitoring systems. Data access should follow applicable privacy rules, consent requirements, and institutional policies. Data provenance and the intended purpose of collection should be documented. C. Preprocessing and Validation Healthcare data may contain missing values, inconsistent units, duplicate records, noise, and incorrect labels. Preprocessing includes quality checks, normalization, transformation, and task-specific feature extraction. Data should be split into training, validation, and test sets without allowing information leakage. When appropriate, evaluation should use separate hospitals, later time periods, or external populations. D. Model Training and Evaluation During training, the model learns relationships between input features and target outcomes. Model selection and parameter tuning should use the training and validation data. The test set should remain independent until final evaluation. Performance metrics must match the clinical purpose. For classification, these may include sensitivity, specificity, precision, F1-score, and area under the receiver operating characteristic curve. Calibration, subgroup performance, and clinical utility should also be assessed where relevant. E. Inference and Clinical Integration The inference layer applies a trained model to new data. Its output may be a risk score, image annotation, classification, or decision support recommendation. Results should be presented in a way that allows clinicians to understand the intended meaning and limitations. An AI recommendation should not automatically become a clinical decision merely because a model produced a numerical score. The workflow should define who reviews the output, when an alert is appropriate, and how uncertain or conflicting results are handled. F. Monitoring and Feedback After deployment, performance may change because of altered patient populations, clinical practices, equipment, or data collection procedures. Monitoring should cover data drift, calibration, subgroup performance, failures, and unintended consequences. Updates require controlled testing, documentation, and appropriate approval before release.

V. APPLICATIONS OF AI IN HEALTHCARE

A. Medical Image Analysis AI models can assist in identifying patterns in radiology and pathology images. Potential tasks include detecting suspicious regions, classifying lesions, segmenting organs, and prioritizing images for review. These tools may support workload management and help clinicians focus on relevant findings. However, image quality, acquisition protocols, patient characteristics, and differences between hospitals can affect model performance. AI findings must be interpreted within the clinical context and confirmed through appropriate professional review. B. Disease Prediction and Early Detection ML models can estimate the likelihood of specific outcomes using clinical history, vital signs, laboratory results, and other relevant features. Potential applications include identifying patients at risk of deterioration, estimating readmission risk, and supporting screening workflows. A high-risk score does not establish that a disease is present. Likewise, a low-risk score does not guarantee that a patient is healthy. The clinical value of a prediction depends on calibration, threshold selection, the consequences of false positives and false negatives, and the actions available to clinicians. C. Personalized and Precision Medicine Patients may respond differently to the same treatment because of differences in genetics, medical history, lifestyle, and other factors. AI can analyze combinations of patient characteristics to support research into treatment selection and outcome prediction. Such predictions require suitable datasets and independent validation. Models should not recommend treatment changes without appropriate clinical review, particularly when evidence is uncertain or patient circumstances are complex. D. Drug Discovery and Development AI can assist researchers in identifying candidate molecules, predicting molecular properties, analyzing biological data, and prioritizing experiments. These methods may reduce the number of candidates requiring detailed laboratory investigation. Nevertheless, computational predictions do not replace experimental validation, preclinical testing, or clinical trials. A promising model output is a research hypothesis, not proof that a medicine is safe or effective. E. Remote Patient Monitoring Wearable devices and connected medical equipment can collect measurements such as heart rate, activity, oxygen saturation, and other physiological signals. AI methods may identify unusual patterns and help prioritize patients for review. Monitoring systems must account for sensor errors, missing measurements, false alarms, connectivity limitations, and patient access to technology. Alerts should be linked to a defined clinical response process rather than generated without a plan for follow-up. Data Sources EHRs, Images, Sensors Data Preparation Cleaning, Validation AI Model Training and Testing Inference Prediction or Detection Clinical Interface Alerts and Visualization Monitoring and Governance Drift, Safety, Performance

Fig. 1. Generalized architecture of an AI-enabled healthcare system.
Fig. 1. Generalized architecture of an AI-enabled healthcare system.

VI. COMPARISON OF AI TECHNIQUES

Table I summarizes common AI techniques and representative healthcare uses. No single technique is suitable for every healthcare problem. Technique selection should be guided by the clinical objective, available data, required interpretability, operational constraints, and the consequences of incorrect predictions.

VII. IMPLEMENTATION CONSIDERATIONS

Developing an AI system for healthcare requires more than selecting a model and measuring its accuracy. The development process should begin with a clearly defined clinical problem and an understanding of how the system will be used. A. Problem Definition The intended use should identify the target population, input data, predicted outcome, user, and clinical action that may follow. Developers should determine whether AI is necessary or whether a simpler statistical method or rule-based approach is sufficient. B. Dataset Preparation Datasets should represent the intended population and relevant clinical settings. Data governance procedures should address authorization, de-identification where appropriate, access control, retention, and secure storage. Labeling guidelines should be documented, particularly when expert annotations are required. C. Model Development Model development involves choosing a suitable algorithm, preprocessing data, training the model, and tuning parameters. Reproducibility requires recording dataset versions, model configurations, software dependencies, and evaluation procedures. D. Evaluation Metrics Accuracy alone can be misleading when the target condition is rare or when errors have unequal consequences. For example, sensitivity measures the proportion of actual positive cases identified by a model, while specificity measures the proportion of actual negative cases correctly identified. These metrics can be expressed as: Sensitivity = TP TP + FN (1) Specificity = TN TN + FP (2) where TP represents true positives, TN true negatives, FP false positives, and FN false negatives. Precision, calibration, predictive values, and decisionanalytic measures should be considered according to the task. Confidence intervals and subgroup analysis can help characterize uncertainty. E. Deployment and Maintenance Deployment may occur within hospital infrastructure or through a secure cloud environment. The chosen design must address availability, access control, latency, interoperability, and recovery from failures. Integration with clinical systems should avoid adding unnecessary work or creating excessive alerts. Maintenance includes monitoring, incident reporting, controlled updates, and reassessment when data or clinical practice changes. A deployed model should have a documented owner and a clear process for handling failures.

TABLE I AI TECHNIQUES AND THEIR HEALTHCARE APPLICATIONS Technique Typical Input Healthcare Application Important Limitation Machine Learning Structured clinical data Risk prediction, outcome estimation, patient classification Data bias, missing values, and poor generalization Deep Learning Images, signals, complex data Image classification, segmentation, signal analysis High data and computing requirements Natural Language Processing Clinical notes and documents Information extraction, summarization, document search Ambiguity and possible incorrect interpretation Computer Vision X-rays, CT, MRI, pathology images Detection, segmentation, image-based classification Image quality and differences between sites Generative AI Text and multimodal inputs Draft documentation, research assistance, patient information Fabricated content, privacy risks, and weak factual grounding Federated Learning Data distributed across institutions Collaborative model training without centralizing raw data Communication cost and residual privacy risks

VIII. BENEFITS AND POTENTIAL IMPACT

AI can offer several benefits when it is designed for a defined clinical or operational need and validated in the intended setting.

  • Decision support: AI can identify patterns and present relevant information to healthcare professionals.
  • Workflow assistance: Automation can reduce selected repetitive tasks, such as document classification or preliminary image prioritization.
  • Early risk identification: Predictive models can help identify patients who may require further assessment.
  • Research acceleration: Computational screening can prioritize candidates for laboratory or clinical research.
  • Continuous monitoring: Properly designed systems can analyze incoming measurements and flag unusual patterns.
  • Resource planning: Forecasting tools can support scheduling and allocation of healthcare resources. These benefits are potential rather than automatic. Realworld impact depends on the quality of the model, the suitability of the workflow, staff training, patient acceptance, and ongoing evaluation. A technically accurate system may still provide little value if it is difficult to use or does not improve decisions and outcomes.

IX. ETHICAL, LEGAL, AND TECHNICAL CHALLENGES

A. Privacy and Data Security Healthcare data can contain highly sensitive personal information. Unauthorized access, insecure data transfers, or inappropriate secondary use can harm patients and undermine trust. Organizations should apply data minimization, encryption, access controls, audit logging, secure development practices, and appropriate retention policies. De-identification can reduce privacy risks, but it does not guarantee that re-identification is impossible in every context. Privacy protection must therefore be part of the full system design. B. Bias and Fairness Bias may arise from unrepresentative datasets, unequal access to healthcare, inconsistent labeling, historical inequities, or the choice of target outcome. A model trained on one population may perform poorly for another. Obermeyer et al. demonstrated that the use of healthcare costs as a proxy for health needs could introduce racial bias into a risk algorithm [7]. This example shows why developers must examine both the data and the assumptions underlying the prediction target. Evaluation should include relevant demographic and clinical subgroups where lawful and appropriate. Identified disparities should be investigated, documented, and addressed. C. Explainability and Transparency Some AI models are difficult to interpret, making it challenging for clinicians to understand why a particular output was produced. Explainable AI methods can provide feature importance estimates, visualizations, or other information about model behavior. However, an explanation is not necessarily a complete or faithful account of a model’s internal reasoning. Explanations should be evaluated for usefulness and should not be presented as proof that a prediction is correct. D. Reliability and Generalization A model may perform differently when clinical equipment, patient characteristics, data collection, or treatment practices change. External validation and post-deployment monitoring are therefore important. Developers should also test performance under missing data, unusual inputs, and operational failures. E. Accountability and Regulation Healthcare AI raises questions about responsibility for decisions, errors, updates, and patient communication. Governance should define the roles of developers, healthcare organizations, clinicians, and other responsible parties. Applicable requirements depend on the system’s intended purpose, jurisdiction, and risk classification. Organizations should consult current laws, regulatory guidance, and institutional policies rather than assume that one approval pathway applies to every AI application. F. Human Oversight AI should support appropriately trained healthcare professionals. The level of human review should reflect the risk and intended use of the system. Patients should not be exposed to automated decisions without suitable safeguards, particularly when errors could result in significant harm.

X. FUTURE SCOPE

Several research directions may improve the safety and usefulness of AI in healthcare. A. Explainable and Trustworthy AI Future systems should provide meaningful information about uncertainty, limitations, and the factors associated with their outputs. Research should examine whether explanations actually help clinicians make better decisions instead of merely making a system appear understandable. B. Federated Learning and Privacy-Preserving Methods Federated learning enables participating institutions to train a shared model while keeping raw data within local environments. It may support collaboration when data centralization is difficult. Nevertheless, model updates can still expose information under some circumstances, and differences between participating datasets can affect performance. Secure aggregation, privacy analysis, and governance remain necessary. C. Multimodal AI Multimodal systems combine different data types, such as clinical notes, medical images, laboratory results, and physiological signals. Combining these sources may provide a richer view of a patient’s condition, but missing information, inconsistent timing, and conflicting signals create additional challenges. D. Human–AI Collaboration Research should evaluate how AI outputs affect clinical decisions, workload, communication, and patient outcomes. Effective collaboration requires suitable interface design, training, clear responsibilities, and the ability to challenge or override an AI recommendation when appropriate. E. Continuous Evaluation Future systems should be evaluated throughout their lifecycle. This includes external validation before deployment, monitoring during use, and reassessment after model or workflow changes. Shared reporting practices can improve transparency and make independent assessment easier.

XI. DISCUSSION

The reviewed literature indicates that AI can contribute to healthcare through image analysis, risk prediction, workflow support, monitoring, and research. The strongest use cases are those with a clearly defined objective, suitable data, measurable outcomes, and a practical process for acting on the model’s output. However, model performance is only one part of clinical value. A system may achieve strong performance on a benchmark dataset but fail to improve patient care when used in a different setting. Similarly, an alerting model may identify relevant events but produce so many false alarms that users stop responding to them. A responsible evaluation should therefore consider technical performance, clinical utility, fairness, safety, usability, privacy, and cost. Independent testing and transparent reporting can help identify limitations before broad deployment. AI should be treated as a component of a larger healthcare system that includes clinicians, patients, administrators, data infrastructure, and governance processes. Its role is to provide useful evidence and assistance while preserving human responsibility for decisions that require clinical judgment.

XII. CONCLUSION

Artificial Intelligence is becoming an important area of healthcare research and technological development. Machine learning, deep learning, computer vision, and natural language processing offer methods for analyzing complex medical data and supporting selected clinical and operational tasks. Applications include medical image analysis, disease-risk prediction, personalized medicine research, drug discovery, remote monitoring, clinical documentation, and hospital resource planning. The adoption of AI also introduces substantial challenges. Data privacy, algorithmic bias, limited interpretability, security risks, model drift, and regulatory obligations must be addressed throughout the system lifecycle. High performance on a test dataset does not by itself demonstrate clinical effectiveness or safety. Future progress will depend on representative data, independent validation, trustworthy system design, continuous monitoring, and meaningful human oversight. Explainable AI, privacy-preserving collaboration, and multimodal learning offer promising research directions, but each requires careful evaluation. Ultimately, AI should complement medical expertise and support safer, more equitable, and more effective healthcare rather than replace the professional and human judgment on which good clinical care depends.

REFERENCES

[1] A. Esteva et al., “Dermatologist-level classification of skin cancer with deep neural networks,” Nature, vol. 542, pp. 115–118, 2017. [2] E. J. Topol, “High-performance medicine: The convergence of human and artificial intelligence,” Nature Medicine, vol. 25, pp. 44–56, 2019. [3] P. Rajpurkar, J. Irvin, K. Zhu, B. Yang, H. Mehta, T. Duan, D. Ding, A. Bagul, C. Langlotz, K. Shpanskaya, M. P. Lungren, and A. Y. Ng, “CheXNet: Radiologist-level pneumonia detection on chest X-rays with deep learning,” arXiv:1711.05225, 2017. [4] X. Liu et al., “A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: A systematic review and meta-analysis,” The Lancet Digital Health, vol. 1, no. 6, pp. e271–e297, 2019. [5] R. Miotto, F. Wang, S. Wang, X. Jiang, and J. T. Dudley, “Deep learning for healthcare: Review, opportunities and challenges,” Briefings in Bioinformatics, vol. 19, no. 6, pp. 1236–1246, 2018. [6] F. Jiang et al., “Artificial intelligence in healthcare: Past, present and future,” Stroke and Vascular Neurology, vol. 2, no. 4, pp. 230–243, 2017. [7] Z. Obermeyer, B. Powers, C. Vogeli, and S. Mullainathan, “Dissecting racial bias in an algorithm used to manage the health of populations,” Science, vol. 366, no. 6464, pp. 447–453, 2019. [8] World Health Organization, Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. Geneva, Switzerland: WHO, 2021. [9] I. Goodfellow, Y. Bengio, and A. Courville, Deep Learning. Cambridge, MA, USA: MIT Press, 2016. [10] Y. LeCun, Y. Bengio, and G. Hinton, “Deep learning,” Nature, vol. 521, pp. 436–444, 2015. [11] E. H. Shortliffe and M. J. Sep´ulveda, “Clinical decision support in the era of artificial intelligence,” JAMA, vol. 320, no. 21, pp. 2199–2200, 2018. [12] A. L. Beam and I. S. Kohane, “Big data and machine learning in health care,” JAMA, vol. 319, no. 13, pp. 1317–1318, 2018. [13] M. P. Sendak et al., “A path for translation of machine learning products into healthcare delivery,” EMJ Innovations, vol. 3, no. 1, pp. 67–72, 2020. [14] D. S. Char, N. H. Shah, and D. Magnus, “Implementing machine learning in health care: Addressing ethical challenges,” New England Journal of Medicine, vol. 378, pp. 981–983, 2018. [15] W. N. Price II and I. G. Cohen, “Privacy in the age of medical big data,” Nature Medicine, vol. 25, pp. 37–43, 2019. [16] J. Amann et al., “Explainability for artificial intelligence in healthcare: A multidisciplinary perspective,” BMC Medical Informatics and Decision Making, vol. 20, article 310, 2020. [17] A. Holzinger, “Explainable AI and multi-modal causability for humancentered healthcare,” in Proceedings of the 2019 IEEE International Conference on Healthcare Informatics, 2019. [18] A. Rajkomar, J. Dean, and I. Kohane, “Machine learning in medicine,” New England Journal of Medicine, vol. 380, pp. 1347–1358, 2019. [19] M. Nasr et al., “Comprehensive privacy analysis of deep learning: Passive and active white-box inference attacks against centralized and federated learning,” in Proceedings of the IEEE Symposium on Security and Privacy, 2019. [20] U.S. Food and Drug Administration, “Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices,” FDA, online resource. Available: https: //www.fda.gov/medical-devices/software-medical-device-samd/ artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices

How to Cite this Contribution

APA Standard

kauravi bhamare et al. (2026). AI In Healthcare. International Journal of Research, Exploration & Knowledge (IJREK), 1(1).

Publication Metadata
Journal:IJREK
Published Date:October 25, 2026
Volume / Issue:Volume 1, Issue 1
Article ID:IJREK-2026-00135
Research Area:Artificial Intelligence
Open Access License

Distributed under Creative Commons Attribution 4.0 International (CC BY 4.0).